FDA Awards SDIX Method Equivalency For Salmonella Enteritidis Detection In Poultry Houses And Eggs
SDIX (NASDAQ: SDIX), a leading supplier of rapid detection solutions to the $1 billion food pathogen testing market, today announced that its RapidChek SELECT Salmonella Enteritidis (SE) test system has been reviewed by the U.S. Food and Drug Administration (FDA) and determined to be equivalent in accuracy, precision and sensitivity to their current standard methods for poultry house ...

Fibrocell Science, Inc. Announces FDA Accepts For Review Complete Response Submission For Azficel-T
Fibrocell Science, Inc. (OTCBB: FCSC), a biotechnology company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and scientific applications, announced that the U.S. Food & Drug Administration (FDA) has accepted for review the Company's complete response submission for azficel-T, proposed brand name laViv , for the treatment of moderate to severe ...

FDA conservatism cuts drug approvals
A number of the largest drugmakers had no medicines cleared in 2010.